Clinical Trial Update: Proteasome Inhibition in Acute Promyelocytic Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating proteasome inhibition for relapsed acute promyelocytic leukemia, with the current status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Promyelocytic Leukemia

Snippet

Sponsor: Christian Medical College, Vellore, India | Conditions: Relapsed Acute Promyelocytic Leukemia | Phase 2 | Status: UNKNOWN